Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,026
Closed -$254K 449
2025
Q3
$254K Sell
3,026
-846
-22% -$69.7K 0.09% 269
2025
Q2
$307K Buy
+3,872
New +$308K 0.16% 176
2025
Q1
Sell
-3,742
Closed -$372K 306
2024
Q4
$372K Buy
+3,742
New +$386K 0.25% 118
2020
Q3
Sell
-12,944
Closed -$955K 158
2020
Q2
$955K Buy
+12,944
New +$974K 0.73% 56
2020
Q1
Sell
-8,325
Closed -$723K 149
2019
Q4
$723K Sell
8,325
-2,824
-25% -$232K 0.53% 74
2019
Q3
$896K Sell
11,149
-46,092
-81% -$3.69M 0.74% 48
2019
Q2
$4.58M Buy
57,241
+26,005
+83% +$1.99M 2.9% 7
2019
Q1
$2.48M Sell
31,236
-8,443
-21% -$631K 1.95% 12
2018
Q4
$2.89M Sell
39,679
-1,091
-3% -$77K 2.23% 10
2018
Q3
$2.76M Sell
40,770
-1,705
-4% -$109K 2.4% 5
2018
Q2
$2.46M Buy
42,475
+14,472
+52% +$816K 2.31% 14
2018
Q1
$1.46M Buy
+28,003
New +$1.51M 1.1% 37

Other funds holding MRK

Diametric Capital's MRK Position: Q4 2025 in Review

Diametric Capital sold out of Merck (MRK) in Q4 2025, closing a stake of 3,026 shares — an estimated $254K sold.

Diametric Capital first reported a position in MRK in Q1 2018 and held it in 12 quarters. The position peaked at $4.58M in Q2 2019. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Diametric Capital reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Diametric Capital sold 3,026 Merck shares in Q4 2025, an estimated $254K.
  • Diametric Capital first reported a position in Merck in Q1 2018 and held it in 12 quarters.
  • Diametric Capital's Merck position peaked at $4.58M in Q2 2019.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Diametric Capital's 13F filing for Q4 2025, filed 13 Feb 2026.